Workflow
医疗器械
icon
Search documents
今日204只个股跨越牛熊分界线
Market Overview - The Shanghai Composite Index closed at 4023.42 points, above the annual line, with a gain of 1.38% [1] - The total trading volume of A-shares reached 30,483.30 billion yuan [1] Stocks Breaking Annual Line - A total of 204 A-shares have surpassed the annual line today, with notable stocks including: - Guanhao Biological (300238) with a deviation rate of 13.10% - Beilu Pharmaceutical (300016) with a deviation rate of 12.97% - Yinkang Life (300143) with a deviation rate of 12.90% [1] Stocks with Significant Deviation Rates - Stocks with high deviation rates include: - Guanhao Biological: 20.00% increase, latest price at 16.62 yuan - Beilu Pharmaceutical: 13.22% increase, latest price at 8.99 yuan - Yinkang Life: 15.18% increase, latest price at 11.38 yuan [1] Additional Stocks with Positive Performance - Other stocks showing positive performance include: - Gangtong Medical (301515) with a 14.16% increase and a deviation rate of 12.82% - Zhite New Materials (300986) with a 20.04% increase and a deviation rate of 10.50% [1] Stocks with Lower Deviation Rates - Stocks that have just crossed the annual line with lower deviation rates include: - Longqi Technology (603341) with a 10.01% increase and a deviation rate of 9.02% - Taihe New Materials (002254) with a 9.98% increase and a deviation rate of 8.61% [1]
天臣医疗:与浪潮数字科技(上海)有限公司签订《战略合作协议》
Mei Ri Jing Ji Xin Wen· 2026-01-05 08:21
每经头条(nbdtoutiao)——秒光!1499元飞天茅台上线即空,i茅台App冲上苹果购物榜第一,10万用 户已下单!经销商同价做回馈,1000箱很快卖完 (记者 王晓波) 每经AI快讯,天臣医疗1月5日晚间发布公告称,天臣医疗与浪潮数字科技(上海)有限公司本着充分 发挥双方资源优势,共同推动医疗智能化、信息化技术在医疗器械设备与耗材的智能化制造、医疗机器 人研发生产等领域的创新应用与产业化落地的战略协同原则,共同商定并于2025年12月31日签署了《战 略合作协议》。 ...
天臣医疗(688013.SH):与浪潮数科签署《战略合作协议》
Ge Long Hui A P P· 2026-01-05 08:20
格隆汇1月5日丨天臣医疗(688013.SH)公布,天臣医疗与浪潮数字科技(上海)有限公司(简称"浪潮数 科")本着充分发挥双方资源优势,共同推动医疗智能化、信息化技术在医疗器械设备与耗材的智能化 制造、医疗机器人研发生产等领域的创新应用与产业化落地的战略协同原则,共同商定并于2025年12月 31日签署了《战略合作协议》。 ...
戴维医疗:产品“电子内窥镜图像处理器”取得注册证
Sou Hu Cai Jing· 2026-01-05 08:17
每经AI快讯,戴维医疗1月5日晚间发布公告称,公司全资子公司宁波维尔凯迪医疗器械有限公司于近 日收到浙江省药品监督管理局颁发的1项《医疗器械注册证》。产品名称为"电子内窥镜图像处理器"。 免责声明:本文内容与数据仅供参考,不构成投资建议,使用前请核实。据此操作,风险自担。 每经头条(nbdtoutiao)——秒光!1499元飞天茅台上线即空,i茅台App冲上苹果购物榜第一,10万用 户已下单!经销商同价做回馈,1000箱很快卖完 每日经济新闻 (记者 曾健辉) ...
九强生物:“铁测定试剂盒(亚铁嗪法)”等产品取得注册证
Mei Ri Jing Ji Xin Wen· 2026-01-05 08:15
每经头条(nbdtoutiao)——秒光!1499元飞天茅台上线即空,i茅台App冲上苹果购物榜第一,10万用 户已下单!经销商同价做回馈,1000箱很快卖完 (记者 曾健辉) 每经AI快讯,九强生物1月5日晚间发布公告称,北京九强生物技术股份有限公司于近日收到北京市药 品监督管理局颁发的《医疗器械注册证》。包括"铁测定试剂盒(亚铁嗪法)"等产品。 ...
天臣医疗:与浪潮数科签署战略合作协议
Xin Lang Cai Jing· 2026-01-05 08:08
Core Viewpoint - The company has signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) Co., Ltd. to promote innovation and industrialization in medical intelligence and information technology [1] Group 1: Cooperation Details - The cooperation aims to advance intelligent manufacturing of medical devices and consumables, as well as the research and production of medical robots [1] - Key areas of collaboration include medical intelligence and information, smart medical devices, medical robots, market synergy, and brand co-construction [1] Group 2: Agreement Impact - The agreement is effective upon the affixing of official seals by both parties and is expected to guide long-term cooperation [1] - It is anticipated that the agreement will not have a direct impact on the company's performance for the fiscal year 2026 and beyond [1]
九强生物(300406.SZ)收到一项医疗器械注册证
智通财经网· 2026-01-05 07:59
智通财经APP讯,九强生物(300406.SZ)公告,公司近日收到北京市药品监督管理局颁发的《医疗器械注 册证》,包括:铁测定试剂盒(亚铁嗪法)、轻链λ测定试剂盒(免疫比浊法)、可溶性生长刺激表达基因2 蛋白测定试剂盒(磁微粒化学发光免疫分析法)。 ...
惠泰医疗:累计回购约40万股
Mei Ri Jing Ji Xin Wen· 2026-01-05 07:58
每经头条(nbdtoutiao)——秒光!1499元飞天茅台上线即空,i茅台App冲上苹果购物榜第一,10万用 户已下单!经销商同价做回馈,1000箱很快卖完 (记者 曾健辉) 每经AI快讯,惠泰医疗1月5日晚间发布公告称,截至2025年12月31日,公司通过上海证券交易所交易 系统以集中竞价交易方式累计回购股份约40万股,占公司总股本约1.41亿股的比例为0.29%,购买的最 高价为256元/股、最低价为235元/股,已支付的总金额为9992.3万元。 ...
戴维医疗:子公司电子内窥镜图像处理器获得医疗器械注册证
Xin Lang Cai Jing· 2026-01-05 07:53
戴维医疗1月5日公告,公司全资子公司宁波维尔凯迪医疗器械有限公司电子内窥镜图像处理器获得浙江 省药品监督管理局颁发的医疗器械注册证。产品与本公司生产的电子内窥镜配套使用,用于在内窥镜诊 断和/或治疗手术中与电子内窥镜连接,有效地在监视器上显示内窥镜观察人体体腔的视场区域的图 像。以上产品医疗器械注册证的取得,有利于丰富公司产品线,进一步提高公司的核心竞争力,对公司 未来的经营成果将产生积极影响。目前尚无法预测该等产品对公司未来营业收入的影响。 ...
2026年首个交易日,A股开门红!
Huan Qiu Wang· 2026-01-05 07:53
Market Overview - On January 5, 2026, the A-share market experienced a strong opening, with all three major indices rising collectively. The Shanghai Composite Index regained the 4000-point mark, closing up by 1.38% [1] - The Shenzhen Component Index increased by 2.24%, while the ChiNext Index rose by 2.85% [1] - The total trading volume in the Shanghai and Shenzhen markets exceeded 2.5 trillion yuan, marking a significant increase of over 500 billion yuan compared to the previous trading day [1] Sector Performance - The market saw a broad-based rally across various sectors, with notable gains in insurance, medical devices, medical services, shipbuilding, semiconductors, precious metals, gaming, electronic chemicals, and biopharmaceuticals [1] - The stocks in the brain-computer interface sector experienced a collective surge, with multiple companies such as Botao Bio, Daoshi Technology, Sanbo Brain Science, and others hitting the 20% daily limit up [1]